Intravenous injection of hybrid liposomes suppresses the liver metastases in xenograft mouse models of colorectal cancer in vivo

European Journal of Medicinal Chemistry

Volumn 57, Issue , 2012, Pages 143-148

  Ichihara, Hideaki ^a   Hino, Motoki ^a   Umebayashi, Masayo ^a   Matsumoto, Yoko ^a   Ueoka, Ryuichi ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Colorectal cancer; Hybrid liposome; Liver metastasis; Xenograft mouse model

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; HL 25; HYBRID LIPOSOME; LIPOSOME; POLIDOCANOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; MOUSE; NONHUMAN; TREATMENT OUTCOME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; COLORECTAL NEOPLASMS; DIMYRISTOYLPHOSPHATIDYLCHOLINE; FEMALE; FLUORESCENT DYES; HUMANS; IN SITU NICK-END LABELING; INJECTIONS, INTRAVENOUS; LIPOSOMES; LIVER NEOPLASMS; MICE; MICE, SCID; ORGAN SIZE; POLYETHYLENE GLYCOLS; SURVIVAL RATE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84867062467     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.08.040     Document Type: Article

References (28)

1. G. Portier, D. Elias, O. Bouche, P. Rougier, J.F. Bosset, J. Saric, J. Belghiti, P. Piedbois, R. Guimbaud, B. Nordlinger, R. Bugat, F. Lazorthes, and L. Bedenne Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial J. Clin. Oncol. 24 2006 4976 4982
2. E.K. Abdalla, J.N. Vauthey, L.M. Ellis, V. Ellis, R. Pollock, K.R. Broglio, K. Hess, and S.A. Curley Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann. Surg. 239 2004 818 825
3. S.K. Maithel, M. Gönen, H. Ito, R.P. Dematteo, P.J. Allen, Y. Fong, L.H. Blumgart, W.R. Jarnagin, and M.I. D'Angelica Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases Surgery 151 2012 162 170
4. R. Ueoka, R.A. Moss, S. Swarup, Y. Matsumoto, G. Strauss, and Y. Murakami Extraordinary micellar enantioselectivity coupled to altered aggregate structure J. Am. Chem. Soc. 107 1985 2185 2186
5. R. Ueoka, Y. Matsumoto, R.A. Moss, S. Swarup, A. Sugii, K. Harada, J. Kikuchi, and Y. Murakami Membrane matrix for hydrolysis of amino acid esters with marked enantioselectivity J. Am. Chem. Soc. 110 1988 1588 1595
6. R. Ueoka, Y. Matsumoto, H. Oyama, H. Takekuma, and M. Iio Effects of flavonoids in hybrid membranes on the activity of tripeptide as an enzyme model and their inhibition of hybridoma growth in vitro Chem. Pharm. Bull. 36 1988 4640 4643
7. I. Kitamura, M. Kochi, Y. Matsumoto, R. Ueoka, J. Kuratsu, and Y. Ushio Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitorsourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study Cancer Res. 56 1996 3986 3992
8. Y. Matsumoto, T. Kato, H. Suzuki, S. Hirose, Y. Naiki, M. Hirashima, and R. Ueoka Highly specific inhibitory effects of three-component hybrid liposomes including sugar surfactants on the growth of glioma cells Bioorg. Med. Chem. Lett. 10 2000 2617 2619
9. R. Ueoka, Y. Matsumoto, S. Hirose, K. Goto, M. Goto, and S. Furusaki Remarkably enhanced inhibitory effects of three-component hybrid liposomes including sugar surfactants on the growth of lung carcinoma cells Chem. Pharm. Bull. 50 2002 563 565
10. Y. Matsumoto, Y. Tanaka, K. Goto, and R. Ueoka Specific fixed aqueous layer of three-component hybrid liposomes related to inhibition of hepatoma cells growth Chem. Lett. 37 2008 118 119
11. K. Goto, Y. Tanaka, Y. Matsumoto, and R. Ueoka Induction of apoptosis of human tumor cells by hybird liposomes including docosahexaenoic acid Bioorg. Med. Chem. Lett. 18 2008 1880 1883
12. Y. Tanaka, K. Goto, Y. Matsumoto, and R. Ueoka Remarkably high inhibitory effects of docosahexaenoic acid incorporated into hybrid liposomes on the growth of tumor cells along with apoptosis Int. J. Pharm. 35 2008 264 271
13. K. Nakano, Y. Iwamoto, W. Takata, Y. Matsumoto, and R. Ueoka Specific accumulation and growth inhibitory effects of hybrid liposomes to hepatoma cells in vitro Bioorg. Med. Chem. Lett. 12 2002 3251 3254
14. H. Nagami, Y. Matsumoto, and R. Ueoka Induction of apoptosis by hybrid liposomes for human breast tumor cells along with activation of caspases Biol. Pharm. Bull. 29 2006 380 381
15. Y. Matsumoto, Y. Iwamoto, T. Matsushita, and R. Ueoka Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells Int. J. Cancer 115 2005 377 382
16. T. Towata, Y. Komizu, S. Suzu, Y. Matsumoto, R. Ueoka, and S. Okada Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo Leuk. Res. 34 2010 906 911
17. H. Nagami, Y. Matsumoto, and R. Ueoka Chemotherapy with hybrid liposomes for lymphoma without drugs in vivo Int. J. Pharm. 315 2006 167 172
18. S. Shimoda, H. Ichihara, Y. Matsumoto, and R. Ueoka Chemotherapy with hybrid liposomes for human breast tumors along with apoptosis in vivo Int. J. Pharm. 372 2009 162 168
19. H. Ichihara, J. Ueno, M. Umebayashi, Y. Matsumoto, and R. Ueoka Chemotherapy with hybrid liposomes for acute lymphatic leukemia leading to apoptosis in vivo Int. J. Pharm. 406 2011 173 178
20. R. Ueoka, Y. Matsumoto, H. Ichihara, and T. Kiyokawa Chemotherapy with hybrid liposomes composed of dimyristoylphosphatidylcholine and polyoxyethylenealkyl ether without drugs M.R. Marten, T.H. Park, T. Nagamune, Biological Systems Engineering ACS Symposium Series 2002 American Chemical Society Washington, DC 177 189
21. H. Ichihara, H. Nagami, T. Kiyokawa, Y. Matsumoto, and R. Ueoka Chemotherapy using hybrid liposomes along with induction of apoptosis Anticancer Res. 28 2008 1187 1196
22. R. Ueoka, Y. Matsumoto, K. Goto, H. Ichihara, and Y. Komizu Membrane targeted chemotherapy with hybrid liposomes for tumor cells leading to apoptosis Curr. Pharm. Des. 17 2011 1709 1719
23. Y. Komizu, Y. Matsumoto, and R. Ueoka Membrane targeted chemotherapy with hybrid liposomes for colon tumor cells leading to apoptosis Bioorg. Med. Chem. Lett. 16 2006 6131 6134
24. Y. Komizu, H. Ueoka, K. Goto, and R. Ueoka Remarkable inhibitory effects of hybrid liposomes on growth of human colon cancer cells through induction of cell cycle arrest along with apoptosis Int. J. Nanomed. 6 2011 1913 1920
25. J.S. Jeong, S.W. Lee, S.H. Hong, Y.J. Lee, H.I. Jung, K.S. Cho, H.H. Seo, S.J. Lee, S. Park, M.S. Song, C.M. Kim, and I.H. Kim Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model Clin. Cancer Res. 14 2008 281 290
26. Y. Matsumoto, T. Kato, S. Iseki, H. Suzuki, K. Nakano, M. Iwahara, and R. Ueoka Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells Bioorg. Med. Chem. Lett. 9 1999 1937 1940
27. S.K. Huang, K.D. Lee, K. Hong, D.S. Friend, and D. Papahadjopoulos Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice Cancer Res. 52 1992 5135 5143
28. H. Ichihara, H. Nagami, K. Yamamoto, Y. Matsumoto, and R. Ueoka Chemotherapy with hybrid liposomes without any drug in vivo Yakugaku Zasshi 123 2003 25 34 (Japanese)